lobbying_filings_raw: 077f0780-54d2-4dfd-90de-86f34aea8a8f

Raw lobbying disclosure filings from the Senate Office of Public Records (SOPR). Each row is a single filing — registrations, quarterly reports, amendments, and terminations. Includes registrant and client names, reported income/expenses, filing period, and the full raw JSON from the API.

This data as json

filing_uuid filing_type registrant_id registrant_name client_id client_name filing_year filing_period received_date amount_reported is_amendment is_no_activity is_termination raw_json registrant_state registrant_country registrant_house_id client_state client_ppb_state client_country client_ppb_country client_general_description client_government_entity affiliated_org_count client_entity_id client_government_unit_id client_match_method client_match_confidence
077f0780-54d2-4dfd-90de-86f34aea8a8f Q2 400531586 CROSSROADS STRATEGIES, LLC 56149 VERTEX PHARMACEUTICALS INCORPORATED 2025 second_quarter 2025-07-19T13:09:11-04:00 30000.0 0 0 0 {"url": "https://lda.gov/api/v1/filings/077f0780-54d2-4dfd-90de-86f34aea8a8f/", "filing_uuid": "077f0780-54d2-4dfd-90de-86f34aea8a8f", "filing_type": "Q2", "filing_type_display": "2nd Quarter - Report", "filing_year": 2025, "filing_period": "second_quarter", "filing_period_display": "2nd Quarter (Apr 1 - June 30)", "filing_document_url": "https://lda.gov/filings/public/filing/077f0780-54d2-4dfd-90de-86f34aea8a8f/print/", "filing_document_content_type": "text/html", "income": "30000.00", "expenses": null, "expenses_method": null, "expenses_method_display": null, "posted_by_name": "Mathew Lapinski", "dt_posted": "2025-07-19T13:09:11-04:00", "termination_date": null, "registrant_country": "United States of America", "registrant_ppb_country": null, "registrant_address_1": "800 North Capitol Street, NW, Suite 800", "registrant_address_2": null, "registrant_different_address": false, "registrant_city": "Washington", "registrant_state": "DC", "registrant_zip": "20002", "registrant": {"id": 400531586, "url": "https://lda.gov/api/v1/registrants/400531586/", "house_registrant_id": null, "name": "CROSSROADS STRATEGIES, LLC", "description": "lobbying firm", "address_1": "800 North Capitol Street, NW, Suite 800", "address_2": null, "address_3": null, "address_4": null, "city": "Washington", "state": "DC", "state_display": "District of Columbia", "zip": "20002", "country": "US", "country_display": "United States of America", "ppb_country": "US", "ppb_country_display": "United States of America", "contact_name": "MATHEW LAPINSKI", "contact_telephone": "+1 202-559-0170", "dt_updated": "2026-01-30T13:29:06.487633-05:00"}, "client": {"id": 56149, "url": "https://lda.gov/api/v1/clients/56149/", "client_id": 56149, "name": "VERTEX PHARMACEUTICALS INCORPORATED", "general_description": "biopharmaceutical company", "client_government_entity": null, "client_self_select": false, "state": "MA", "state_display": "Massachusetts", "country": "US", "country_display": "United States of America", "ppb_state": "MA", "ppb_state_display": "Massachusetts", "ppb_country": "US", "ppb_country_display": "United States of America", "effective_date": "2023-06-01"}, "lobbying_activities": [{"general_issue_code": "HCR", "general_issue_code_display": "Health Issues", "description": "General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about non-opioid pain therapies.H.R.1227/S.475 Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 143773, "prefix": "ms", "prefix_display": "MS.", "first_name": "CHERYL", "nickname": null, "middle_name": "LYNN", "last_name": "JAEGER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 66496, "prefix": null, "prefix_display": null, "first_name": "JASON", "nickname": null, "middle_name": "BENJAMIN", "last_name": "VAN PELT", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 107303, "prefix": null, "prefix_display": null, "first_name": "BRITTANY", "nickname": null, "middle_name": "JOHNSON", "last_name": "HERNANDEZ", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 58561, "prefix": null, "prefix_display": null, "first_name": "MATHEW", "nickname": null, "middle_name": null, "last_name": "LAPINSKI", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 151117, "prefix": "mr", "prefix_display": "MR.", "first_name": "STEPHEN", "nickname": null, "middle_name": "THOMAS", "last_name": "VOLJAVEC", "suffix": null, "suffix_display": null}, "covered_position": "Legislative Director, Rep. Vern Buchanan; Legislative Assistant, Senator Marsha Blackburn", "new": true}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MED", "general_issue_code_display": "Medical/Disease Research/Clinical Labs", "description": "General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about precision medicine.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 143773, "prefix": "ms", "prefix_display": "MS.", "first_name": "CHERYL", "nickname": null, "middle_name": "LYNN", "last_name": "JAEGER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 66496, "prefix": null, "prefix_display": null, "first_name": "JASON", "nickname": null, "middle_name": "BENJAMIN", "last_name": "VAN PELT", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 107303, "prefix": null, "prefix_display": null, "first_name": "BRITTANY", "nickname": null, "middle_name": "JOHNSON", "last_name": "HERNANDEZ", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 58561, "prefix": null, "prefix_display": null, "first_name": "MATHEW", "nickname": null, "middle_name": null, "last_name": "LAPINSKI", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 151117, "prefix": "mr", "prefix_display": "MR.", "first_name": "STEPHEN", "nickname": null, "middle_name": "THOMAS", "last_name": "VOLJAVEC", "suffix": null, "suffix_display": null}, "covered_position": "Legislative Director, Rep. Vern Buchanan; Legislative Assistant, Senator Marsha Blackburn", "new": true}], "government_entities": [{"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}, {"general_issue_code": "MMM", "general_issue_code_display": "Medicare/Medicaid", "description": "General education about federal policies impacting pharmaceutical development, approval, and reimbursement. Education about the importance of access to non-opioid pain therapies for Medicare beneficiaries. H.R.1227/S.475 Alternatives to Prevent Addiction in the Nation (Alternatives to PAIN) Act.", "foreign_entity_issues": "", "lobbyists": [{"lobbyist": {"id": 143773, "prefix": "ms", "prefix_display": "MS.", "first_name": "CHERYL", "nickname": null, "middle_name": "LYNN", "last_name": "JAEGER", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 66496, "prefix": null, "prefix_display": null, "first_name": "JASON", "nickname": null, "middle_name": "BENJAMIN", "last_name": "VAN PELT", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 107303, "prefix": null, "prefix_display": null, "first_name": "BRITTANY", "nickname": null, "middle_name": "JOHNSON", "last_name": "HERNANDEZ", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 58561, "prefix": null, "prefix_display": null, "first_name": "MATHEW", "nickname": null, "middle_name": null, "last_name": "LAPINSKI", "suffix": null, "suffix_display": null}, "covered_position": null, "new": false}, {"lobbyist": {"id": 151117, "prefix": "mr", "prefix_display": "MR.", "first_name": "STEPHEN", "nickname": null, "middle_name": "THOMAS", "last_name": "VOLJAVEC", "suffix": null, "suffix_display": null}, "covered_position": "Legislative Director, Rep. Vern Buchanan; Legislative Assistant, Senator Marsha Blackburn", "new": true}], "government_entities": [{"id": 34, "name": "Health & Human Services, Dept of (HHS)"}, {"id": 2, "name": "HOUSE OF REPRESENTATIVES"}, {"id": 1, "name": "SENATE"}]}], "conviction_disclosures": [], "foreign_entities": [], "affiliated_organizations": []} DC US   MA MA US US biopharmaceutical company   0 2067154   normalized_name_state 0.9

Links from other tables